Lymphoma Trial, Recruiting NCT06941194 Sponsor: Istituto Oncologico Veneto IRCCS Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT06941194
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older, of any gender
  • People who have been diagnosed with a high-grade (grade III) soft tissue sarcoma (a type of cancer affecting soft tissues such as muscle or fat) located in the arms or legs, confirmed by laboratory testing of a tissue sample
  • People who have already received radiotherapy before surgery (either a short or long course of treatment)
  • People whose doctors have recommended wide radical excision surgery (an operation to remove the tumour along with a surrounding margin of healthy tissue)
  • People whose CT scan shows no signs of the cancer having spread to other parts of the body
  • People who are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

  • People diagnosed with a non-cancerous (benign) tumour
  • People whose sarcoma is located in the abdomen (retroperitoneal area) or the trunk of the body
  • People whose planned surgery involves removing an entire limb at the hip or shoulder joint
  • People for whom complete surgical removal of the tumour is not expected to be possible
  • People whose surgery would require removal or repair of a major blood vessel
  • People who have received or are planned to receive other local treatments to the affected area, such as isolated limb perfusion or electrochemotherapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 34722887055

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituto Oncologico Veneto IRCCS
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
1 November 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Primary objective and endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov